Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Using thalidomide against pathological neovascularization].

Arik Eisenkraft, Shai Luria, Eyal Robenshtok

    Harefuah
    |April 17, 2003
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diagnostic Performance of ACR TI-RADS and Sonographic Predictors of Malignancy in Pediatric Thyroid Nodules.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
    Same author

    Achieving balance in upper limb spasticity management.

    The Journal of hand surgery, European volume·2026
    Same author

    Intrapatient variability in the number of retrieved oocytes and ovarian response categories between consecutive in vitro fertilization cycles.

    Fertility and sterility·2026
    Same author

    Treatment management algorithm for natural frozen embryo transfer cycles using a real-time ovulation prediction machine learning model.

    Scientific reports·2026
    Same author

    BRAF and MEK inhibition beyond dabrafenib-trametinib in advanced thyroid cancer: a real-world case series.

    Frontiers in endocrinology·2026
    Same author

    Brain Metastases From Differentiated Thyroid Cancer in the Era of Targeted Therapies: A Multi-Center Retrospective Cohort.

    Head & neck·2025
    Same journal

    [Tennis Elbow Among Players].

    Harefuah·2026
    Same journal

    [Internal Medicine - My Mission].

    Harefuah·2026
    Same journal

    [Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

    Harefuah·2026
    Same journal

    [Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

    Harefuah·2026
    Same journal

    [Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

    Harefuah·2026
    Same journal

    [Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

    Harefuah·2026
    See all related articles

    Thalidomide, known for its teratogenic effects, also possesses anti-angiogenic properties. This review explores its potential to treat pathological neovascularization, particularly in mustard gas eye injuries.

    Area of Science:

    • Ophthalmology
    • Pharmacology
    • Toxicology

    Context:

    • Thalidomide, initially used in the 1950s-60s, was later recognized as a potent teratogen.
    • Despite its teratogenicity, thalidomide exhibits anti-inflammatory and anti-angiogenic properties, leading to its approval for treating leprosy.
    • Mustard gas exposure can cause pathological corneal neovascularization, a condition lacking effective treatments.

    Purpose:

    • To review current research on thalidomide's anti-angiogenic potential.
    • To investigate the possible application of thalidomide in treating mustard gas-induced eye injuries and corneal neovascularization.

    Summary:

    • This review examines thalidomide's anti-angiogenic and anti-inflammatory effects.
    • It explores the potential therapeutic role of thalidomide in managing pathological neovascularization, specifically in the context of mustard gas eye injuries.

    Related Experiment Videos

  • Current research on thalidomide's efficacy against corneal neovascularization is evaluated.

    • Impact:

    • Provides insights into novel therapeutic strategies for mustard gas eye injury.
    • Highlights thalidomide's potential repurposing for treating ocular neovascularization.
    • Addresses the unmet need for effective treatments for pathological corneal neovascularization.